Nearly three months after winning a contentious bid to buy obesity drugmaker Metsera Inc. for $10 billion, Pfizer Inc. reported its first statistically significant top-line data of the acquired lead, ...

The child was reportedly hospitalized after accidentally using her mother's GLP-1 injector, a class of medications that ...

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked.

Serena Williams' Super Bowl LX ad with Ro is sparking debate, as it promotes weight loss with GLP-1s. Here's what to know.

Novo Nordisk beat analyst expectations for the fourth quarter, but the result was overshadowed by softened expectations for ...

In the world of obesity research, the arrival of GLP-1 drugs like Ozempic feels seismic. At a recent conference, Martin Binks, a leader in obesity research, found himself marveling with a colleague: ...

Meanwhile, the U.K.'s Medicines and Healthcare Products Regulatory Agency updated its warnings on GLP-1 and dual GLP-1/GIP ...

Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock here.

A new pilot study shows how protein and fiber may help people on GLP-1 medications lose weight while protecting muscle mass.

Langers is working on making the No Worries GLP-1 support beverage available through both online and retail locations. It’s already available via Amazon.com, and Langer said the Texas-based Spec’s ...

Airlines treat weight like an enemy hiding everywhere. For decades, carriers trimmed ounces wherever possible, paper stock got thinner, seat frames lost bulk, and in-flight magazines vanished.

Restaurants are adding smaller, protein-focused meals as drugs like Wegovy change how people eat, and these items often cost less than full-size entrées.